Researchers locate what triggers breast, prostate cancers
March 17th, 2009 - 5:22 pm ICT by IANSWashington, March 17 (IANS) Researchers have identified what triggers breast and prostate cancers.
Ercole Cavalieri and Eleanor Rogen of University of Nebraska Medical Centre, who conducted the research, were quoted as saying in a Nebraska release: “We have found the first step that starts a cell down the road to becoming a cancer cell”.
“By blocking this first step from happening, we feel we can stop the development of breast and prostate cancer,” they added in the release.
The researchers have discovered that certain estrogen derivates (metabolites) can react with deoxyribo-nucleic acid (DNA) to cause damage that may initiate the start of breast and prostate cancer.
Estrogen can initiate cancer when natural protective mechanisms do not function properly in the body, which then allows estrogen metabolites to react with DNA.
Since both men and women have naturally occurring estrogen, the triggering mechanism for breast and prostate cancer is identical.
This research has been funded in part by nearly $40 million in direct funding from the National Cancer Institute and the US Defence Department.
Cavalieri and Rogan are the first cancer researchers to study the effects of Resveratrol on this process. New research establishes that to be effective additional compounds must be added for optimal effect.
The combination of naturally occurring preventative agents Resveratrol, N-Acetyl-L-Cysteine (NAC), Lipoic Acid and Melatonin greatly enhances the body’s natural protection mechanisms which, in turn, decrease the triggering mechanism involved in the formation of breast and prostate cancer cells, said the Nebraska release.
These compounds are available in a recently developed dietary supplement called Preventium that promises to reduce people’s risk for breast and prostate cancer
- Scientists identify triggering mechanism behind the start of breast, prostate cancer - Mar 17, 2009
- Red wine compound 'can give a boost to breast cancer treatment' - Feb 15, 2011
- Red wine compound can halt breast cancer - Oct 02, 2011
- Red wine makes cancer drug more potent - Feb 15, 2011
- Breast cancer cells control multiple genes in response to estrogen - Jul 20, 2010
- Wonder drug could kill all types of cancer - Jun 27, 2011
- Australian scientists identify new way to treat prostate cancer - Feb 26, 2010
- Folic acid protects offsprings from colon cancer - May 27, 2011
- Drug counters bone-damaging effects of breast cancer medication - Oct 10, 2011
- High soy intake reduces risk of breast cancer - Jun 15, 2010
- Antibiotic used in meat, dairy industry slows prostate cancer growth - Dec 21, 2010
- How contraceptives may may cause high BP - May 27, 2011
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
- Higher levels of folate in RBCs linked to silenced tumor-suppressors - Dec 23, 2010
- Conventional theory of modern drug design challenged - Oct 11, 2010
Tags: acid dna, cancer cell, cancer researchers, cavalieri, defence department, lipoic acid, metabolites, n acetyl l cysteine, national cancer institute, nebraska medical, optimal effect, prostate cancer, prostate cancer cells, prostate cancers, protection mechanisms, protective mechanisms, resveratrol, rogan, rogen, university of nebraska
